Experimental group:There are no restrictions on this study.
Sponsors
Guang'anmen Hospital
Conditions
Circulation system, cardiology, non communicable diseases
Phase 4
Post-marketing clinical safety evaluation of Shexiang Tongxin dropping pill and centralized monitoring in hospitals
Active, not recruitingChiCTR2300070706
Start: 2023-04-14Updated: 2023-06-04
Post-marketing clinical safety evaluation of Shexiang Tongxin dropping pill and centralized monitoring in hospitals
Active, not recruitingITMCTR2023000008
Start: 2023-05-10Updated: 2023-05-29